CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-06 | Forrester Robert President and C.E.O. | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-04-06 | Feder Julie B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-01-05 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2018-01-05 | Le NgocDiep T. MD, PhD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2018-01-05 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-01-05 | Feder Julie B CFO, PFO and PAO | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-05 | Forrester Robert President and CEO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-01-03 | Lobacki Joseph M Executive VP & CCO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2017-12-05 | BARBERICH TIMOTHY J Director | Purchase | +60,538 | $3.95 | $239K | 130,000 |
| 2017-10-09 | Le NgocDiep T. MD, PhD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2017-09-19 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 100,000 | ||
| 2017-09-19 | Forrester Robert President, CEO and Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 100,000 | ||
| 2017-09-06 | Stuglik Brian M Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2017-09-05 | Rowinsky Eric K Director | Purchase | +2,000 | $3.84 | $8K | 2,000 |
| 2017-07-10 | Feder Julie B CFO, PFO and PAO | Grant or award · Stock Option (Right to Buy) | +370,000 | 370,000 | ||
| 2017-06-13 | Lawton Alison Frances Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Wendel Bruce Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Rowinsky Eric K Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 21 of 23 · 448 trades